Trioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquine

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 10, 2007, Pages 3768-3770

  Loup, Christophe ^a   Lelièvre, Joël ^a,b   Benoit Vical, Françoise ^a,b   Meunier, Bernard ^c  

^a CNRS   (France)

^b CHU RANGUEIL   (France)

^c Palumed   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ; ARTESUNATE; CHLOROQUINE; DU 1301; DU 2303; HEMATIN; HEME; HEMOZOIN; PRIMAQUINE; TRIOXAQUINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; CULTURE MEDIUM; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; IN VITRO STUDY; MALARIA; NONHUMAN; PRIORITY JOURNAL;

ALKYLATION; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DIOXANES; HEME; HEMEPROTEINS; PLASMODIUM; SESQUITERPENES; SPECTROPHOTOMETRY, INFRARED;

EID: 34948841945     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00239-07     Document Type: Article

References (21)

1. Benoit-Vical, F., J. Lelièvre, A. Berry, C. Deymier, O. Dechy-Cabaret, J. Cazelles, C. Loup, A. Robert, J.-F. Magnaval, and B. Meunier. 2007. Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob. Agents Chemother. 51:1463-1472.
2. Dechy-Cabaret, O., F. Benoit-Vical, C. Loup, A. Robert, H. Gornitzka, A. Bonhoure. H. Vial, J.-F. Magnaval, J.-P. Séguéla, and B. Meunier. 2004. Synthesis and antimalarial activity of trioxaquine derivatives. Chem. Eur. J. 10:1625-1636.
3. Deharo, E., R. N. Garcia, P. Oporto, A. Gimenez, M. Sauvin, V. Jullian, and H. Ginsburg. 2002. A non-radiolabelled ferriprotoporphyrin IX biomineralisation inhibition test for the high throughput screening of antimalarial compounds. Exp. Parasitol. 100:252-256.
4. Dorn, A., S. R. Vippagunta, H. Matile, A. Budendorf, J. L. Vennerstrom, and R. G. Ridley. 1998. A comparison and analysis of several ways to promote haematin (haem) polymerisation and an assessment of its initiation in vitro. Biochem. Pharmacol. 55:737-747.
5. Egan, T. J. 2002. Physico-chemical aspects of hemozoin (malaria pigment) structure and formation. J. Inorg. Biochem. 91:19-26.
6. Egan, T. J., D. C. Ross, and P. A. Adams. 1994. Quinoline anti-malarial drugs inhibit spontaneous formation of β-hematin (malaria pigment). FEBS Lett. 352:54-57.
7. Egan, T. J., R. Hunter, C. H. Kaschular, H. M. Marques, A. Misplon, and J. Walden. 2000. Structure-function relationships in aminoquinolines: effect of amino and chloro- groups on quinoline-hematin complex formation, inhibition of β-hematin formation, and plasmodial activity. J. Med. Chem. 43:283-291.
8. Fitch, C. D., G.-Z. Cai, Y.-F. Chen, and J. D. Shoemaker. 1999. Involvement of lipids in ferriprotoporphyrin IX polymerization in malaria. Biochim. Biophys. Acta 1454:31-37.
9. Haynes, R. K., D. Monti, D. Taramelli, N. Basilico, S. Parapini, and P. Olliaro. 2003. Artemisinin antimalarials do not inhibit hemozoin formation. Antimicrob. Agents Chemother. 47:1175.
10. Kannan, R., D. Sahal, and V. S. Chauhan. 2002. Heme-artemisinin adducts are crucial mediators of the ability of artemisinin to inhibit heme polymerisation. Chem. Biol. 9:321-332.
11. Laurent, S. A, C. Loup, S. Mourgues, A. Robert, and B. Meunier. 2005. Heme alkylation by artesunic acid and trioxaquine DU1301, two antimalarial trioxanes. ChemBioChem 6:653-658.
12. Ncokazi, K. K., and T. J. Egan. 2005. A colorimetric high-throughput β-hematin inhibition screening assay for use in the search for antimalarial compounds. Anal. Biochem. 338:306-319.
13. Olliaro, P. L., R. K. Haynes, B. Meunier, and Y. Yuthavong. 2001. Possible mode of action of the artemisinin-type compounds. Trends Parasitol. 17: 122-126.
14. Pagola, S., P. W. Stephens, D. S. Bohle, A. D. Kosar, and S. K. Madsen. 2002. The structure of malaria pigment β-haematin. Nature 404:307-310.
15. Parapini, S., N. Basilico, E. Pasini, T. J. Egan, P. Olliaro, D. Taramelli, and D. Monti. 2000. Standardization of the physicochemical parameters to assess in vitro the β-haematin inhibitory activity of antimalarial drugs. Exp. Parasitol. 96:249-256.
16. Robert, A., F. Benoit-vical, C. Claparols, and B. Meunier. 2005. The antimalarial drug artemisinin alkylates heme in infected mice. Proc. Natl. Acad. Sci. USA 102:13676-13680.
17. Robert, A., J. Cazelles, and B. Meunier. 2001. Characterization of the alkylation product of heme by antimalarial drug artemisinin. Angew. Chem. Int. Ed. Engl. 40:1954-1957.
18. Solomonov, I., M. Osipova, Y. Feldman, C. Baehtz, K. Kjaer, I. K. Robinson, G. T. Webster, D. McNaughton, B. R. Wood, I. Weissbuch, and L. Leiserowitz. 2007. Crystal nucleation, growth, and morphology of the synthetic malaria pigment β-hematin and the effect thereon by quinoline additives: the malaria pigment as a target of various antimalarial drugs. J. Am. Chem. Soc. 129:2615-2627.
19. Tripathi, A. K., S. I. Khan, L. A. Walker, and B. L. Tekwani. 2004. Spectrophotometric determination of de novo hemozoin/β-hematin formation in an in vitro assay. Anal. Biochem. 325:85-91.
20. Vennerstrom, J. L., E. O. Nuzum, R. E. Miller, A. Dorn, L. Gerena, P. A. Dande, W. Y. Ellis, R. G. Ridley, and W. K. Milhous. 1999. 8-Aminoquinolines active against blood stage Plasmodium falciparum in vitro inhibit hematin polymerization. Antimicrob. Agents Chemother. 43:598-602.
21. Vippagunta, S. R., A. Dorn, H. Matile, A. K. Bhattacharjee, J. M. Karle, W. Y. Ellis, R. G. Ridley, and J. L. Vennerstrom. 1999. Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth. J. Med. Chem. 42:4630-4639.